Examine Case Study: A Middle-Aged Caucasian Man With Anxiety. You will be asked to make three decisions concerning the medication to prescribe to this patient. Be sure to consider factors that might impact the patient’s pharmacokinetic and pharmacodynamic processes.

At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.

Introduction to the case (1 page)

• Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.

Decision #1 (1 page)

• 1.Which decision did you select?
•  
• 2.Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• 3.Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• 4.What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
• 5.Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
•  

Decision #2 (1 page)

• 1.Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• 2.Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• 3.What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
• 4.Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #3 (1 page)

• 1.Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• 2.Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• 3.What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
• 4.Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Conclusion (1 page)

• 1.Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.

Note: Support your rationale with a minimum of five academic resources. While you may use the course text to support your rationale, it

Decision Point One

Begin Paxil 10 mg po daily

RESULTS OF DECISION POINT ONE

• Client returns to clinic in four weeks
• Client informs you that he has no tightness in chest, or shortness of breath
• Client states that he noticed decreased worries about work over the past 4 or 5 days
• HAM-A score has decreased to 18 (partial response)

Decision Point Two

Increase dose to 20 mg po daily

RESULTS OF DECISION POINT TWO

• Client returns to clinic in four weeks
• Client reports an even further reduction in his symptoms
• HAM-A score has now decreased to 10. At this point- continue current dose (61% reduction in symptoms)

Decision Point Three

Maintain current dose

Guidance to StudentAt this point, it may be appropriate to continue client at the current dose. It is clear that the client is having a good response (as evidenced by greater than a 50% reduction in symptoms) and the client is currently not experiencing any side effects, the current dose can be maintained for 12 weeks to evaluate full effect of drug. Increasing drug at this point may yield a further decrease in symptoms, but may also increase the risk of side effects. This is a decision that you should discuss with the client. Nothing in the client’s case tells us that we should consider adding an augmentation agent at this point as the client is demonstrating response to the drug. Avoid polypharmacy unless symptoms cannot be managed by a single drug.